Feng
Ding
*a,
Yuna
Qian
bc,
Zaian
Deng
b,
Jitai
Zhang
a,
Yongchao
Zhou
a,
Lan
Yang
a,
Fangyan
Wang
d,
Juping
Wang
e,
Zhihua
Zhou
f and
Jianliang
Shen
*bc
aDepartment of Microbiology & Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P. R. China. E-mail: 293599983@qq.com; Fax: +86-577-88017536; Tel: +86 -577-88017536
bSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
cWenzhou Institute of Biomaterials and Engineering, Chinese Academy of Science, Wenzhou, Zhejiang, China. E-mail: shenjl@wibe.ac.cn
dDepartment of Pathophysiology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P. R. China
eDepartment of Pathophysiology, School of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P. R. China
fSchool of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, P. R. China
First published on 21st April 2021
Retraction of ‘Size-selected silver nanoparticles for MALDI-TOF mass spectrometry of amyloid-beta peptides’ by Feng Ding et al., Nanoscale, 2018, 10, 22044–22054, DOI: 10.1039/C8NR07921H.
Signed: Feng Ding, Yuna Qian, Zaian Deng, Jitai Zhang, Yongchao Zhou, Lan Yang, Fangyan Wang, Juping Wang, Zhihua Zhou, Jianliang Shen
Date: 7th April 2021
Retraction endorsed by Charlotte Marshall, Managing Editor, Nanoscale
This journal is © The Royal Society of Chemistry 2021 |